Ishii Satoshi

イシイサトシ | Ishii Satoshi

Affiliation and department：
Other affiliations (1)：

株式会社グライコファーマ代表取締役

Research field (4)： Pathobiochemistry , Pharmacology , Pharmaceuticals - health and biochemistry , Structural biochemistry

Research keywords (6)：シャペロン治療 , リソソーム病 , 糖脂質 , Chemical chaperone , Lysosomal disease , Glycolipid

Research theme for competitive and other funds (2)：

1998 - 2008 Chaperone therapy for Fabry disease
2002 - 2005 Gene therapy for Fabry disease

Papers (20)：

Hiroki Maruyama, Kaori Miyata, Mariko Mikame, Atsumi Taguchi, Chu Guili, Masaru Shimura, Kei Murayama, Takeshi Inoue, Saori Yamamoto, Koichiro Sugimura, et al. Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genetics in medicine : official journal of the American College of Medical Genetics. 2019. 21. 8. 1900-1900
Hiroki Maruyama, Kaori Miyata, Mariko Mikame, Atsumi Taguchi, Chu Guili, Masaru Shimura, Kei Murayama, Takeshi Inoue, Saori Yamamoto, Koichiro Sugimura, et al. Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genetics in medicine : official journal of the American College of Medical Genetics. 2019. 21. 2. 512-515
Kinoshita N, Hosomi N, Matsushima H, Nakamori M, Yagita Y, Yamawaki T, Torii T, Kitamura T, Sueda Y, Shimomura R, et al. Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2018. 27. 12. 3563-3569
Maruyama H, Taguchi A, Nishikawa Y, Guili C, Mikame M, Nameta M, Yamaguchi Y, Ueno M, Imai N, Ito Y, et al. Medullary thick ascending limb impairment in the Gla^tmTg(CAG-A4GALT) Fabry model mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2018. 32. 8. 4544-4559
Maruyama H, Miyata K, Mikame M, Taguchi A, Guili C, Shimura M, Murayama K, Inoue T, Yamamoto S, Sugimura K, et al. Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis. Genetics in medicine : official journal of the American College of Medical Genetics. 2018. 21. 1. 44-52

ｍore...

MISC (3)：

Patents (4)：

Method for enhancing mutant enzyme activities in lysosomal storage disorders
Method of enhancing lysosomal α-galactosidase A
Method for enhancing mutant enzyme activities in lysosomal storage disorders
Method of enhancing lysosomal α-galactosidase A

Education (4)：

- 1986 Tokyo University of Pharmacy and Life Sciences Graduate School of Pharmacy
- 1986 Tokyo University of Pharmacy and Life Science Graduate School, Division of Pharmaceutical Sciences Biological Chemistry
- 1981 Tokyo University of Pharmacy and Life Sciences School of Pharmacy School of Pharmacy
- 1981 Tokyo University of Pharmacy and Life Science Faculty of Pharmaceutical Science Pharmaceutical Science

Professional career (2)：

Doctor (Pharmaceutical Science) (Tokyo University of Pharmacy and Life Science)
Master (Parmaceutical) (Tokyo University of Pharmacy and Life Science)

Work history (16)：

2009 - 現在 Oita University Faculty of Medicine
2003 - 現在 Professor, Obihiro University of
2003 - 2009 Obihiro University of Agriculture and Veterinary Medicine Professor
2001 - 2002 米国マウントサイナイ医科大学客員教授
2001 - 2002 Visiting Associate Professor, Mount Sinai

Show all

Awards (2)：

1995 - 上原記念生命科学財団研究員奨励賞
1995 - Research Award from the Uehara Memorial Foundation

Association Membership(s) (4)：

日本生化学会 , The Japanese Cancer Association , ThePharmaceutical Society of Japan , The Japanese Biochemical Society

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page